CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Synergy Pharmaceuticals Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Synergy Pharmaceuticals Inc.
420 Lexington Avenue
Room 2012
Phone: (212) 297-0020p:212 297-0020 New York, NY  10170-2099  United States Fax: (212) 297-0019f:212 297-0019
This company is no longer actively traded on any major stock exchange.
Business Summary
Synergy Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of novel gastrointestinal (GI) therapies. Its gastrointestinal (GI) platform is based on uroguanylin. Uroguanylin physiologically regulates bowel function, fluid balance, and stool consistency.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/201812/31/2017YesYesYes-Yes

Industries
SIC Code Description
2834 Pharmaceutical preparations
5990 Retail stores, not elsewhere classified
8731 Commercial physical and biological research
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board Gary S.Jacob 71 12/13/2017 7/1/2008
Chief Executive Officer, Director TroyHamilton 46 1/19/2018 7/8/2015
Chief Financial Officer, Executive Vice President Gary G.Gemignani 53 4/17/2017 4/17/2017
6 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Callisto Pharmaceuticals, Inc. 420 Lexington Avenue New York NY United States

Business Names
Business Name
SGYP
SGYPQ
Synergy Advanced Pharmaceuticals, Inc.
Synergy Pharmaceuticals Inc

General Information
Outstanding Shares: 248,037,301 (As of 11/9/2018)
Shareholders: 643
Stock Exchange: OTC
Federal Tax Id: 203823853
Fax Number: (212) 297-0019


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023